引用本文:[点击复制]
[点击复制]
【打印本页】 【在线阅读全文】【下载PDF全文】 查看/发表评论下载PDF阅读器关闭

←前一篇|后一篇→

过刊浏览    高级检索

本文已被:浏览 2074次   下载 147 本文二维码信息
码上扫一扫!
吉非替尼相关皮疹程度与表皮生长因子受体各位点突变关系的护理观察
蒋慧
0
()
摘要:
目的皮生长因子。方法结果结论
关键词:  
DOI:
基金项目:
454000 (19)E-mail Nursing observation of the relationship between the degree of gefitinib associated rash and the point mutation of EGFR
()
Abstract:
Objective To investigate the correlation between the extent of gefitinib associated rash and the mutation of epithelial growth factor receptor (EGFR) in patients. Methods We selected 50 lung adenocarcinoma patients who received gefitinib treatment with rash in the period from May 2016 to May 2017, record the extent of skin rash and the mutation of EGFR site. The expression of EGFR was divided into 6 types, Include18 exon positive, 19 exon positive, 21 exon positive, 18 and 19 exon positive, 19 and 21 exon positive, 18 and 21 exon positive. use the Spearman Correlate find whether there was a significant correlation between the two. Results The Spearman Correlate show that there was no significant difference between the 6 types of skin rashes. Conclusion There was no correlation between the occurrence of rash and the expression of EGFR, the experimental error may be due to the small sample size. Later, by increasing the sample size, again to confirm it
Key words:  

用微信扫一扫

用微信扫一扫